 outcome days age low birth weight infants single dose synthetic surfactant identical double-blind trials administration single ml/kg dose synthetic surfactant Exosurf Neonatal delivery infants birth weights gm rates survival bronchopulmonary dysplasia trials planned sample sizes availability Exosurf provisions Treatment Investigational New Drug program combined results trials Study infants birth weight gender random assignment treatment regimen ninety-two infants Exosurf air placebo study groups similar variety demographic features mothers pregnancies circumstances births infants Exosurf-treated infants oxygen respiratory support first days life comparison air-treated infants infants Exosurf group pulmonary interstitial emphysema Exosurf group significant reduction combined outcome neonatal death survival bronchopulmonary dysplasia significant increase rates survival disease differences treatment groups incidences variety complications prematurity apnea patent ductus arteriosus intraventricular hemorrhage enterocolitis improvements respiratory physiology single prophylactic dose Exosurf result increased likelihood neonatal survival bronchopulmonary dysplasia